Navigation Links
Outcome of common medications

Despite the fact that doctors know the power of a common heart medication in reducing the risk of heart attacks and heart failure, many patients do not take the medications. Research shows the use of beta-blocker medication after a heart attack// can reduce the risk of early death by 20 percent. However, many patients fear side effects such as depression, fatigue and sexual dysfunction and, therefore, do not take the drugs. A new study finds there is a gap in the information available.

Researchers from Yale University and the University of Alabama report patients and doctors consider the side effects to be numerous, but in the past the research didn't support those beliefs. In a new study, the researchers worked to determine the true side effects of beta-blockers. Doctors reviewed files of 35,000 patients in 15 clinical trials. They found no increased risk in depression but say there was a very small increase in fatigue and sexual dysfunction.

The researchers conclude that the conventional wisdom that beta blocker therapy is associated with substantial risks of depressive symptoms, fatigue and sexual dysfunction is not supported from data from clinical trials. The risks of these adverse effects should be put in the context of these medications. In the end, the investigators urge doctors to prescribe beta-blockers when necessary and to monitor patients for the side effects.


'"/>




Page: 1

Related medicine news :

1. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
2. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
3. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
4. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
5. SPECT Can Help Predict Treatment Outcome In Patients With Low Back Pain
6. PET Scans Could Predict Treatment Outcomes In Cancer
7. Prostate Cancer Outcomes Determined By Socioeconomic Status
8. Shared Care Results In Better Breast Cancer Outcomes
9. Mayo Clinic Researchers Find Two New Genes Predict Breast Cancer Outcomes
10. Magnesium Levels to Detect the Outcome of Brain Injury
11. Transparency in Probable Outcomes of Cosmetic Surgeries Necessary
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Outcome common medications

Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 2Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 3RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2